Company Filing History:
Years Active: 2023-2024
Title: Moritz Widmaier: Innovator in Computational Pathology
Introduction
Moritz Widmaier is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of computational pathology, particularly in the development of innovative techniques for tissue analysis. With a total of 2 patents, his work is paving the way for advancements in medical diagnostics.
Latest Patents
Widmaier's latest patents focus on using a first stain to train a model that predicts the regions stained by a second stain. This innovative approach employs a convolutional neural network to identify regions of a tissue slice that would be stained by the first stain, based solely on tissue stained by the second stain. This method eliminates the need for the first stain to mark cancerous regions on other tissue slices stained with the second stain. The training slice is stained with both a first immunohistochemical stain and a second counterstain. Image analysis is utilized to identify a target region of the training slice based on the first stain. A set of parameters for associated mathematical operations is optimized to train the model to classify pixels of the image as belonging to the target region based on the second stain, without relying on the first stain. The trained parameters are stored in a database and can be applied to other images of tissue that are not stained with the first stain.
Career Highlights
Moritz Widmaier is currently employed at AstraZeneca Computational Pathology GmbH, where he continues to push the boundaries of computational techniques in pathology. His work is instrumental in enhancing the accuracy and efficiency of cancer diagnostics.
Collaborations
Widmaier collaborates with notable colleagues, including Tobias Wiestler and Simon Lanzmich. Their combined expertise contributes to the innovative projects at AstraZeneca.
Conclusion
Moritz Widmaier's contributions to computational pathology through his patents and collaborative efforts are making a significant impact in the field of medical diagnostics. His innovative approaches are set to transform how tissue analysis is conducted, ultimately benefiting patient care.